期刊文献+

HPVL1在不同宫颈病变组织中的表达规律探讨 被引量:1

Expression pattern of HPV L1 in different cervical lesion tissues
下载PDF
导出
摘要 目的探讨影响HPV L1蛋白在肿瘤组织内表达的因素,寻找HPV L1蛋白在不同宫颈病变中的表达规律。方法收集不同宫颈病变组织,检测标本内HPV16和HPV18基因分型及基因组物理状态;用ELISA、蛋白质印迹和免疫组织化学方法检测标本内HPV L1的表达情况。结果共收集到48例标本,其中42例HPV16阳性,3例HPV18阳性。HPV16阳性标本中,25例病毒基因组为游离型,7例为混合型,10例为整合型;HPV18阳性标本全部为整合型。ELISA及蛋白质印迹检测显示,随着病变程度的加重,HPV L1的表达量有逐渐降低的趋势。免疫组织化学显示,组织内的HPV L1阳性反应有多种形式,依病变组织内病毒基因组物理状态、病变组织分化程度以及病变进程的不同而不同。结论 HPV L1在宫颈病变组织内的表达有一定的结构基础,其表达量与病毒基因组在病变组织和细胞内的物理状态、肿瘤组织的分化程度、病毒基因组插入宿主基因组基因序列的状态有着非常密切的关系。 Objective To explore the factors influencing the HPV L1 protein expression in tumor tissues and to understand the expression pattern of HPV L1 protein in different cervical lesion tissues. Methods Different cervical lesion tissues were collected to detect genotypes and genome physical states of HPV 16 and 18. ELISA, Western blotting analysis, and immunohistochemical staining were used to examine the expression of HPV L1 protein in the tissues. Results A total of 48 specimens were collected, with 42 being HPV16 positive and 3 being HPV18 positive. In HPV16 positive specimens, 25 harbored exclusively the episomal form, 7 carried mixed forms, and 10 had integrated type. All the HPV18 positive specimens belonged to the integrated type. The results of ELISA and Western blotting analysis displayed that HPV L1 expression decreased with the aggravation of the lesion severities. The immunohistochemistry findings showed that L1 positive reactions were of different forms and varied with different physical states of viral genome, differentiation degrees, and progression of lesion tissues. Conclusion HPV L1 expression in cervical lesion tissues has its structural foundation, and the expression levels are closely related to many factors, including the physical state of virus genome in lesion tissues, differentiation degrees of tumor tissue, and the state of virus gene sequence being inserted into host ones.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2014年第12期1337-1346,共10页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(307770104) 湖北省自然科学基金(2011CDC002)~~
关键词 人乳头瘤病毒 主要外壳蛋白 宫颈肿瘤 基因组 物理状态 human papillomavirus major capsid protein uterinecervical neoplasms geneome physical state
  • 相关文献

参考文献24

  • 1SchillerJ T, Castellsague X, Garland S M. A review of clinical trials of human papillomavirus prophylactic vaccines[J]. Vaccine,2012,30(SuppI5):FI23-FI38.
  • 2Thanes N, Muller M. Oral immunization with different assembly forms of the HPV 16 major capsid protein Ll induces neutralizing antibodies and cytotoxic T-lymphocytes[J]. Virology, 2007,369: 375-388.
  • 3DoorbarJ ,Quint W .Banks L,Bravo I G,Stoler M,Broker T R, et al. The biology and life-cycle of human papillomaviruses[J]. Vaccine, 2012, 30(Suppl 5) : F55-F70.
  • 4DoorbarJ. The papillomavirus life cycle[J].J Clin Virol,2005,32(Suppll):7-15.
  • 5Zheng Z M, Baker C C. Papillomavirus genome structure, expression, and post-transcriptional regulation[J]. Front Biosci , 2006,11: 2286-2302.
  • 6时艳梅,肖长义,叶红,王雅琴,吴江锋.临床宫颈组织标本HPV16 L1蛋白检测[J].基础医学与临床,2010,30(8):807-810. 被引量:3
  • 7Lee H,Lee KJ ,Jung C K,HongJ H,Lee Y S,Choi YJ ,et al. Expression of HPV Ll capsid protein in cervical specimens with HPV infection[J]. Diagn Cytopathol , 2008,36: 864-867.
  • 8Yoshida T, Sa no T, Kanuma T, Owada N, Sakurai S, Fukuda T, et al. Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesionsJ J}. Cancer, 2008, 114: 83-88.
  • 9Corden S A, Sant-Cassia LJ, Easton AJ, Morris A G. The integration of HPV-18 DNA in cervical carcinoma[J]. Mol Pathol,1999,52:275-282.
  • 10Peitsaro P,Johansson Bv Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique[IJ.J Clin Microbiol , 2002,40: 886-89l.

二级参考文献46

  • 1王丽芳,肖长义.机体对HPV L1免疫应答的研究进展[J].免疫学杂志,2006,22(z1):51-54. 被引量:1
  • 2张艳,李宁丽.人类乳头瘤病毒免疫致病机制[J].现代免疫学,2006,26(6):523-526. 被引量:15
  • 3潘凌亚.HPV感染与宫颈癌前病变[J].基础医学与临床,2006,26(12):1296-1301. 被引量:26
  • 4[2]Parkin DM,Pisani P,Ferlay J.Estimates of the worldwide incidence of 25 major cancers in 1990[J].Int J Cancer,1999,80(6):827-841.
  • 5[3]Walboomers JM,Jacobs MV,Munoz N,et al.Human papil lomavirus is a necessary cause of invasive cervical cancer worldwide[J].J Pathol,1999,189(1):12-19.
  • 6[5]Modis Y,Trus BL,Harrison SC.Atomic model of the papil lomavirus capsid[J].EMBO J,2002,21(18):4754-4762.
  • 7[8]Brown DR,Fife KH,Wheeler CM,et al.Early assessment of the efficacy of a human papillomavirus type 16 LI virus-like particle vaccine[J].Vaccine,2004,22(21/22):2936-2942.
  • 8[9]Keam SJ,Harper DM.Human papillomavirus types 16 and 18 vaccine(recombinant,ASM adjuvanted,adsorbed)[Cer varix][J].Drugs,2008,68(3):359-372.
  • 9[10]Huang CM.Human papillomavirus and vaccination[J].Mayo Clin Proc,2008,83(6):701-706.
  • 10[11]Villa J,Munoz N,Perez G,et al.Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV(types 6/11/16/18)vaccine clinical trials[J].Curr Med Res Opin,2008,24(6):1623-1634.

共引文献14

同被引文献22

  • 1Couto E,Saeterdal I,Juvet LK,et al. HPV catch-up vac- cination of young women: a systematic review and meta- analysis [J]. B MC Public Health, 2014, 14 ( 3 ) : 867 - 868.
  • 2Plesa A,Anton G,Iancu IV,et al. Molecular variants of human papilloma virus 16 E2,E4,ES,E6 and E7 genes associated with cervical neopIasia in Romanian patients [J]. Arch Virol, 2014,159(12) : 3305-3320.
  • 3Shen G,Cheng J,Wang Y,et al. Viral DNA load of high- risk human papilloma virus is closely associated with the grade of cervical lesions [J]. Int J Clin Exp Med, 2014,7 (12) : 5826-5831.
  • 4Ronco G,Giorgi-Rossi P,Carozzi F,et al. Efficacy of hu- man papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia:a randomised controlled trial [J]. Lancet Oncol, 2010,11 (3) : 249-257.
  • 5Cuzick J,Arbyn M,Sankaranarayanan R,et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and develop- ing countries[J]. Vaccine,2008,26(10):29-41.
  • 6Lyng FM,Traynor D, Ramos IR, et al. Raman spectroscopy for screening and diagnosis of cervical cancer [J]. Anal Bioanal Chem, 2015,407 (27) : 8279-8289.
  • 7Lee SJ,Lee AW,Kang CS,et al. Clinicopathological im- plications of human papilloma virus (HPV) L1 capsid pro- tein immunoreactivity in HPV16-positive cervical cytolo- gy [J]. Int J Med Sci, 2014,11 (1) : 80-86.
  • 8黄斌,李瑞珍,刘志红,乌兰娜,李鹃,王纯,周艳秋,翁立明,吴瑞芳.HPV L1壳蛋白在宫颈脱落细胞中的表达及临床意义[J].华中科技大学学报(医学版),2009,38(6):824-828. 被引量:19
  • 9杨滨,娄晓明,姜囡,杨帆,李婉萍.子宫颈癌患者血清中HPV检测的临床意义[J].广东医学,2011,32(8):1002-1003. 被引量:9
  • 10王伟,吴王飞,钱宁,李凤山.HPV阳性宫颈细胞学标本及活检组织中L1蛋白表达及意义[J].临床与实验病理学杂志,2011,27(9):985-987. 被引量:7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部